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Abstract
The complex [Pt2CI2(Spym)4], where Spym 2-mercaptopyrimidine, was synthesized and
analyzed spectroscopically. The presence in the 95pt NMR spectrum, of only one signal for the
Pt(lll) indicates the symmetrical arrangement of the ligands and the identical setting of N, S and CI
atoms, PtS2CIN2, for the two Pt atoms being different to other compounds described in the
literature. The interaction of this complex with DNA was studied by several techniques, including
circular dichroism, melting temperature determination, electron microscopy (EM) and atomic force
.microscopy (TMAFM). Preliminary results show a high activity against HL-60 and HeLa tumour lines
for the Pt-2-memaptopyrimidine complex in comparison with cisplatin activity. Higher values for IC5o
were obtained, while the values of LD50 were lower than those for cisp/atin.
Introduction
2-Mercaptopyrimidine is a potential model of biologically relevant molecules such as 2-
thiouracil and 2-thiocosine that are sometimes present in t-RNA, and it has also been tested as
bacterial growth inhibitor and antiviral agent(’) However, until now, it has not been used as a drug.
The development of the pyrimidine blues, poiymeric compounds in which mixed-valence metal
ions, usually platinum, are bridged by ligands derived from pyrimidines or amides, and the discovery
of their high antitumour activity have extended the study to pyrimidine related-Pt(lll) complexes.
Several Pt(lll) dimers have [been described(4) and the structure of a dimer of Pt(lll) with 2-
mercaptopyrimidine was determined by Goodgame et a/. (5).
There are several possibilities of coordination for the 2-mercaptopyrimidine molecule
(Figure 1 ). It can bind to the metal as a neutral ligand via the S atom (A), or in bidentate fashion via N
and S atoms (B), or as an anionic ligand (C), or finally as a bridging ligand to two metal atoms (D).
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Figure 1. Several coordination possibilities for 2-mercaptopyrimidine
Several compounds of 2-mercaptopyrimidine with various metals are described:
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Abbot et aL(6) studied the complexes M(Spym)2 (M=Co, Ni, Zn) with anionic and bidentate Spym;
M(Spym)2X2 (M=Mn, Fe, Co, Ni and X=Br, CI), tM=Zn and X=CI) (M=Cd and X=Br, CI and I) with
an!oni.c and bidentate Spym; Rosenfield et al.( described the complex (Et4N)[Ni(Spym)3] with
anionic and bidentate Spym; Taqui Khan et aL(s) found complexes of two types,
[PdCl(Met)(Spym)]CI with neutral and monodentate Spym, and [Pd2CI2(Spym)2] with anionic and
bidentate Spym; finally, Goodgame et aL() have synthesized the compounds [Pt2X2(Spym)4],
(X=CI, I) and [Pt2CI2(Spym)5], where the oxidation state of platinum is III or a mixture of III and IV
respectively. In several attempts to synthesize the mononuclear compounds of 2-
mercaptopyrimidine and Pt(ll) in 1:1 or 2:1 ratios, we always obtained_the same compound
[Pt2CI2(Spym)4], identified as that studied crystallographically by Goodgame(5) (Figure 2).
Here we present a complete spectroscopic study together with a description of its effect on
DNA structure and the results of several biological tests.
EXPERIMENTAL
Materials and Methods
The complex Pt-Spym was prepared using K2[PtCI4] Johnson Matthey and 2-
mercaptopyrimidine Aldrich. Elemental analyses were carried out on a Carlo Erba 1500
microanalyzer at the Serveis Cientffico-Tcnics at the University of Barcelona. The infrared spectra
were recorded in solid star? (KBr pellets) on an FT-IR Nicolet 5DZ spectrometer in the 4000-400
cm" range. H{3C}, 3C{H} and 95pt{H}NMR spectra were obtained on a Brucker DRX 250
sp.ectrometer using DMSO-d6 as solvent. Chemical shifts were measured relative toTMS in the case
ofH and 3C and to Na2PtCI6 for 95pt.
UV spectra were recorded at room temperature on a double beam SHIMAZDU UV-2101-PC
spectrometer. The absorbance change during DNA denaturalization (Tin) was measured on the
same SHIMAZDU UV-2101-PC spectrometer with thermostatic cells connected to an automatic
temperature regulator NESLAB RTE-110 bath. The heating rate was 1.5 9C/min. The absorbance
was measured at , 260 nm. CD spectra were obtained on a JASCO J720 spectropolarimeter with a
450W xenon lamp.
Samples, prepared as described below, were observed on transmission electronic
microscopes Philips EM 200 and Philips EM 301 at 80,000 V, the first working at 25,800 and
54,900 magnification and the second at 16,000, 20,000 and 26,000 magnification. Over 82.5 ml
TAE, 25 ml 0.1% cytochrome c, 25 ml 38% formaldehyde and 610 ml pure water solution, the
adduct PBR322:Pt-Spym with ri 0.50 and 72 h of incubation was added. Microdrops were
prepared from this solution and after 20 rain Ni MESH200 grills recovered with FORMVAR
membrane and reinforced with graphite were deposited over DNA drops. The samples were shaded
by evaporation of WO3 in an evaporation chamber at 5.10.6 torr, under nitrogen atmosphere for 10
rain by a 20 A and 150W current with a rotation of 100 rpm.
Images of linear DNA, 200 base-pair copy of Escherichia coli, and adducts of Pt compounds
and this DNA were obtained with Extended Nanoscope III (Digital Instruments, Santa Barbara, CA)
working in TMAFM mode in about 100 nN. The samples were prepared as described above and 2 ml
of each was deposited on a small mica disk, washed in distilled water after 20 rain, and dried under
argon.
In vitro studies, cytotoxicity in tumour lines and type of cell death were determined in Centro
de Biologia Molecular "Severo Ochoa" at Universidad Aut(noma de Madrid-CSIC.
Synthesis of the Complex
1 mmol of K2PtCI4 was dissolved in 10 ml of water and mixed with a suspension of 1 mmol of
2-mercaptopyrimidine (Spym) in 10 ml of hot water. After a few minutes a pale brown precipitate was
formed and after stirring for 3 h at 40C and 48 h at room temperature a dark brown solid appeared.
The product was filtered off the orange solution, washed with H20 and ethanol and finally dried over
silica gel. Calculated for [Pt2CI2(Spym)4] C, 21.18; N, 12.35; H, 1.55; S, 14.12; CI, 7.81. Found: C,
21.42; N, 12.07; H, 1.60; S, 13.84; CI, 7.87.
When the synthesis was repeated using the ratio K2PtCI4 Spym 1:2, the same product was
obtained while the solution remained colourless.
RESULTS AND DISCUSSION
FT-IR Spectra
The IR data for 2-merca.ptopyrimidine and theplatinum complex are shown in Table 1
The band at 1217 cm-
was assigned to Vst(SH) of the thiol form, and the band t 1188 cm-
.was assigned to v(NH) and v(C=S) of the thiona form.
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Table 1" Main IR frequencies (cm-) of 2-mercapt0pyrimidine and Pt-Spym
ASSIGNMENT Spym Pt-Spym
Vst(SH)
v(NH)
v(C=C)+v(C=N)
v(C-S)thiol+(ring)
v(C=S)thiona+(ring)
(thioamida III)
t(CS) out plane +’y(CH)
(thioamida IV)
,(C-S)+(ring)out plane
v(Pt-S)
v(Pt-CI)
5(Pt-N)
’s: strong, m: medium, w: v’eak
2618,2521
2841,2730
1609 vs 1605s
1570 S 1575s
1542m
1217m 1248m
1188s 1175m
983m 1026w
1024w
746m 752s
471m 484m
440,432w
296w
225w
These results indicate that the two tautomeric thiol and thiona forms are present in the solid (3,10-12).
Three weak bands at 2063, 1977 and 1915 cm" assigned to aromatic ring combination bands
disappeared when the complex was formed due to the electronic changes induced by the
coordination of the metal ion. The band at 1188 cm-1 assigned to v(C=S) of the thiona form ( 1,13-14)
in 2-mercaptopyrimidine decreased in frequency and intensity in the complex indicating the
coordination through the S atom (5). In contrast, the band at 1217 cm-1 corresponding to v(C-S) of
the thiol form increased in frequency when the metal ion bound to 2-mercaptopyrimidine. The other
bands related with S bonds also showed changes in frequency and intensity. Special attention
should be given to the thioamide bands resultin.q in the coupling between different vibrations when
a C=S group is bound to one or more N atoms (5). The band assigned to thioamide III (v(C=N) +
v(C=S) at 983 cm-1 split and increased in frequency in the complex [Pt2CI2(Spym)4], as has been
observed for bidentate (N,S) compounds. On the other hand, the Vst(SH) bands disappeared,
indicating that the thiol form is not p_resent when the metal ion is coordinated by sulphur. A new
band corresponding to v(Pt-S)(8, 16-18) was also observed for the complex. The splitting of the band
assigned to v(C=C) + v(C=N) at 1570 cm-
in the Pt compound indicates that the pyrimidine ring may
be involved in the coordination to the metal. The appearance of a new band at 225 cm-1 assigned to
5(M-N) (8,9, 2o) and the behaviour of the thioamide III band seem to reinforce this hypothesis. A new
band at 296 cm-
can also be observed. Although the bands corresondin.q to terminal v(Pt-CI) in
Pt(ll) compounds appeared at frequencies between 345 and 310 cm-l(9,21,22), the Pt(lll) dimers with
terminal CI showed the v(Pt-CI) absorption at lower frequencies(23,24). This shifting is due to the
lengthening of the Pt-CI bond caused by the trans effect of the Pt-Pt bond of the dimer(5,25-27). So,
the FT-IR data are consistent with the coordination of the four 2-mercaptopyrimidine molecules by
both sulfur and nitrogen atoms bridging the two Pt(lll) atoms. Each metal atom is bound to one
terminal CI atom.
H, 13C and 95pt NMR Study
The main chemical shifts assigned in the 1H NMR spectrum of the 2-mercaptopyrimidine and
the compound [Pt2CI2(Spym)4] are shown in Table 2. In the spectrum of the free 2-
mercaptopyrimidine, a complex pattern appears at low frequency, corresponding to H(5) coupled
with the neighbouring protons. The signal observed at 8.29 ppm is assigned to H(4) and H(6). The
presence of a broad signal at 12.85 ppm, assigned to NH proton, together with the observed
equivalence of H(4) and H(6) suggests a fast exchange of the NH proton between sites and 3.
The major form in DMSO is the thiona form(28). Several changes can be observed in the Pt complex
spectrum in comparison to that of the free 2-mercaptopyrimidine. The H(4) and H(6) are no longer
equivalent. The signal corresponding to NH disappeared, indicating that the ligand is deprotonated
and that it coordinates in bidentate fashion via S and N atoms. The large downfield shift (0.95 ppm)
observed for H(4) suggests that N(3) is involved in the coordination. The signal assigned to H(5)
appeared as a triplet with a J value of 4.9 Hz, as expected for an ortho coupling. The H(4) and H(5)
are coupled with J=4.4 Hz, which is in agreement with values reported elswhere for this type of
ligand. The signal assigned to H(6) is not well resolved and it is not possible to determine the J
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value. In the case of other Pt(lll) complexes similarH NMR signals were observed (25). Although the
complex can react with DMSO and the Pt-Pt bond can be broken easily to give monomeric species, no solvolysis signal was obseved. The low- temperature (246K) spectrum is the same as that
recorded at room temperature.
Table 2: Chemical shifts (ppm) from H NMRa spectrum of 2-mercaptopyrimidine and
t-Spym
Assignment "’NH- H4’ H H5
Spym 12.85w 8.29s 8.29s 6.86m
Pt-Spym b 9.24d 8.68s 7.36t
a" registered in DM’SO at room T inter refe:ence:TMS)
b: not observed m:complex pattern d:double t:triplet w:wide
In Table 3 the 13C shifts for 2-mercaptopyrimidine and the compound [Pt2CI2(Spym)4] are
presented.
Table 3: Chemical shifts (ppm) in 13C NMRa spectrum of 2-mercaptopyrimidine and Pt-
Spym
Assignment C 2 C 4 C 6
Spym 181.97 154.37w 154.37TM
Pt,Spym... 180.69 158.63 157.36
w: wide a" in DMSO at room T (internal reference:TMS)
In the complex, the equivalence between C(4) and C(6) signals is lost. The most noticeable
shift corresponds to C(5), followed by C(4) and C(6). The quaternary C(2) appears as a very weak
signal showing only an insignificant shift due to the low sensitivity of carbon atoms of this kind. The
large shift of C(5) can be explained because this atom is in para with respect to the S atom
coordinated to the pt(29). The N coordinated to the metal atom is probably the closest to C(4)
because the corresponding signal shifts more than that assi.qned to C(6).
Finally, the 195pt spectrum for the complex [Pt2CI2(pym)4], shows a single signal at -1179
ppm, related to K2PtCI6, which represents an intermediate shift between those of Pt(ll) and Pt(IV) for
a similar environment, and which corresponds to an oxidation state of Pt(111)(27,30,31).
The presence of only one signal for the Pt(lll) indicates the symmetrical arrangement of the
ligands and the identical setting of N, S and CI atoms PtS2CIN2, for the two Pt atoms. In the case of
the analogous compound described by Goodgame( )the crystal structure indicates that two types
of Pt environment, PtSCIN3 and PtS3CIN maybe r)resent. The different chemical environment must
lead to the appearance of two signals in the 195pt spectrum but the authors did not reported
anything about it. However, the ecLui.valent dimer compound with iodine [Pt212(Spym)4], also studied
crystallographically by Goodgameua, presents the same chemical environment PtS21N2 for both Pt.
Circular Dichroism
The circular dichroism spectra of Caff Thymus DNA and Caff Thymus DNA incubated with
the mercaptopyrimidine-Pt compound at several times and with several molar ratios were registered. In Tables 4a, 4b and 4c, the Omax and Omin for Xmax and ,mi, values at different ri and incubation
times, can be observed.
’C 5 "’1
109.42
117.76
Table 4a: CD of DNA:Pt-Spym complex at different molar ratios
(incubation time16 h
ri Omaxa )naxo min
DNA 8.78 276.3 -9.77
0.01 8.48 277.8 -9.83
0.10 8.88 275.8 -9.95
0.25 8.24 271.1 -11.61
0.50 7.92 277.7 -8.84
a: -C.cmZ.dmol’.10 b: nm
min
245.6
245.7
244.6
241.5
246.0
The major changes occur for ri 0.25. There was a slight modification of DNA spectrum
when the Pt-Spym complex was bound to the helix. This change was more marked at 16 h of
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incubation. The positive band has less ellipticity than the DNA one and this effect, together with the
increase of the ellipticity and the decrease of the wavelength, indicate changes in the base
stacking, probably due to the opening of the helix(32) The behaviour is very similar to that induced
by transplatin, which originates helix opening due t’o the binding between the two strains of the
same DNA helix. The structure of the Pt-Spym compound that presents two labile sites (CI) at the
ends of the dimer can allow a similar type of binding.
Table 4b: CD of DNA:Pt-Spym at different molar ratios
(incubation time 48 h
ri e.,.x"
DNA 8.61 276.0 -9.34 245.0
0.01 8.36 277.2 -9.07 245.6
0.10 8.82 274.2 -9.48 244.6
0.25 8.93 275.4 -9.55 245.8
0.50 8.53 276.2 -9.22 246.4
a: C.cmZ,dmol-
.10 b: nm
Table 4c: CD of DNA:Pt-Spym at different times. (ri=0.25).
tc Omaxa )Lmaxo Omin min
DNA 8.48 277.0 -9.83 245.6
16 8.24 271.1 -11.61 241.5
24 7.94 276.6 -12.22 241.2
48 8.93 275.4 -9.55 245.8
a: C.cmZ,dmol-
10a b: nm c: h
However, after 48 h of incubation, the changes are less marked, although the greatest
alteration occurs also for ri 0.25. In this case the main change is the stabilization of the double helix
and the increased coiling. Probably, the long time of incubation produces the disappearance of the
interaction observed at 16 h.
The ellipticity of the positive band decreases when compared to that of DNA at 16 h and 24
h and increases slightly at 48 h. In contrast, the ellipticity of the negative band always increases and
reaches the major change at 24 h for ri 0.25. The type of interaction observed at 16 h remains until
24 h which is when the major change occurs. It is probable that the adduct formed, DNA:Pt-Spym,
remains only until 24 h.
UV. Melting Temperature (Tm)
The wavelengths and the absorbances corresponding to the maximum UV of the complex
DNA:Pt(Spym) are collected in Table 5.
Table 5: UV wave lenghts and maximum absorbancea of DNA:Pt-Spym complex at
.different (16 and 8 .h)
COMPLEX ri 16 h 48 h
axo Abs naxo Abs
DNA 258.6 0.365 258.1 0.373
DNA:Pt-Spym 0.01 258.3 0.368 258.9 0.369
DNA:Pt-Spym 0.10 258.3 0.382 257.5 0.383
DNA: Pt-Spym 0.25 257.3 0.388 258.0 0.400
DNA:Pt-Spym 0.50 257.2 0.471 256.5 0.587
a: (Abs DNA:complex Abs complex) at 25C b: nm
The percentages of hyperchromicity (positive value) or hypochromicity (negative value) at
260 nm and the AA270/AA295 ratio are shown in Table 6.
In the adduct DNA:Pt-Spym a strong shifting of the maximum towards lower wavelenghts
was observed. This effect is greater for higher ri values (0.25, 0.50) and a progressive increase in
the hyperchromicity when the Pt/nucleotide ratio increased was also observed. This seems to
indicate a strong modification of the secondary DNA structure. Going from ri 0.25 to ri 0.50 a
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b
Figure 3. Microphotographs corresponding to plasmid alone (a), and to plasmid incubated
for 24 h. with Pt-Spym at ri 0.50 (b)
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Figure 4. TMAFM images corresponding to linear fragments of DNA, hliM (a), to the same DNA
incubated for 24 h. with cisplatin (b), incubated for 24 h. with Pt-Spym (c), and incubated for 24 h.
with Spym alone (d)
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strong change of percentage H and z,270/AA295 was also observed. Probably, the interaction with
DNA of a bulk compound with two weak sites on opposite sides of the complex causes uncoiling of
the double helix and destabilizes the secondary DNA structure at room temperature. The values of
,270/,295 indicate that the Pt compound interacted with the DNA.
Table 6: % hyperchromicitya (+) or hypochromicity(-) at 260 nm and Z,270/Z,295b ratio in DNA:Pt-
DNA: Pt-Spym 0.01 +1.1 1.0 -0.4 1.7
DNA:Pt-Spym 0.10 +4.7 1.6 +2.4 2.0
DNA:Pt-Spym 0.25 +5.8 0.4 +6.7 3.3
DNA:Pt-Spym 0.50 +27.1 7.0 +53.4 2.2
b: (Abs DNA:complex- Abs DNA)270/(Abs DNA:complex- Abs DNA)295
The compound Pt-Spym induces a slight decrease in Tm. In compounds having intercalator
aromatic rings the values found for ATm are in the range 0.4-1 C for CT- DNA at pH= 7.0 (33).
On the other hand, this compound caused an important decrease in the absorbance at high
temperatures.
These results together with the UV spectrum indicated a marked interaction with the DNA at
room temperature.
Electron Microscopy
In Figure 3, the microphotographs corresponding to plasmid alone(a), to plasmid incubated
with cisp/atin at ri 0.50 for 24 h (b), and to plasmid incubated with Pt-Spym at ri 0.50 for 24 h (c)
are shown. The plasmid alone is in circular closed form with different degrees of supercoiling, and a
low percentage of linear form can also be seen. The cisplatin causes a comlactation in the plasmid,
as has been described in the literarure (34) which can reach up to 50 %. The Pt-Spym compound
also causes a compactation, but also lateral aggregation with other plasmid molecules. This
compactation is more intense than that of cisp/atin in the same experimental conditions. This fact
may indicate that the Pt-Spym compound induces some kind of interaction between different
plasmid molecules, probably due to the binding of platinum with two strains from two different
molecules.
Atomic Force Microscopy (TMAFM)
Figure 4 shows the images corresponding to linear fragment DNA, hliM (a), the same DNA
incubated 24 h with cisp/atin (b), incubated 24 h with Pt-2-mercaptopyrimidine (c), and 24 h with 2-
mercaptopyrimidine alone (d). The concentration in DNA is the same in all the samples. Cisplatin
seems to compact and distort. In the magnification corresponding to 400 nm, several points where
the fragment is doubled can be observed. The measurement of the length of this fragment on the
microscope reveals this modification. The measurement of the area also shows that there is no
aggregation between different linear DNA fragments. So, the binding type of cisplatin to DNA,
mainly to two N intra-strain sites, is reflected. However, after DNA incubation with Pt-Spym, always in
the same conditions as for cisp/atin, aggregation and compacting phenomema were observed. The
aggregate formed have larger area than a single fragment, indicating that the presence of the
complex has produced the aggregation of several DNA fragments. So, the binding of Pt-Spym
induces an interaction between different DNA strains. Probably, it binds through the two lateral Sites
after Pt-CI has been hydrolyzed. The effect observed is not due to the ligand. The effect on the
DNA in the same conditions as for 2-mercaptopyrimidine alone can be observed in Figure 4(c). The
measurement of the length of the strain on the microscope confirms that neither lengthening or
distorsion has been caused.
Preliminary Cytotoxicity tests on Tumour lines
The tests have been carried out on two tumour lines: HeLa cells from an uterus cancer and
HL-60 cells from human leukemia. The trials were performed with cisplatin as reference, and with
the Pt-2-mercaptopyrimidine complex. The LC50 parameters are summarized in Tables 7 and 8.
The values for the Pt-Spym are better than for the cisp/atin against the tumour line HL-60.
The percentage of cell death is high at very low concentrations of complex, 3.5 mM, which is
markedly lower than the one obtained for cisp/atin.
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Table 7: LCso forcisplatin and Pt-Spym in the tumour line HL-60
,Cmpund’,’, LCs(l.tM) ’LCso(lglm I)
cisplatin 35.0 10.5
Pt-Spym 3.5 3.3
Table 8: LCso for cisplatin and Pt-Spym in the tumour line HeLa
Compound LCso(12M) LCso(tg/ml) ,I
isplatin 37.0 11.1
Pt-Spym 3.5 3.3
The difference between cisplatin and the Pt-Spym compound is still greater for the tumour
line HeLA. Although the LC50 value for Pt-Spym is the same, cell death is practically complete at 5
mM. For cisplatin, the same effect was produced only at concentrations near 150 mM. 2-
Mercaptopyrimidine alone did not produce cell death. Probably the dramatic effects of the platinum
complex over DNA are related with the structure of the complex but the possible role of the
oxidation state III of the platinum in the mechanisms of cytotoxicity cannot be ruled out(35).
The analysis of the type of cell death was carried out with two kinds of tests: the observation
of the characteristic morphological changes by means of phase contrast microscopy and the
checking of DNA digestion in regular fragments by gel electrophoresis. This exposure in HeLA
cells, at 16 or 24 h, produced the characteristic changes due to apoptosis.
The same test was carried out with the tumour line HL-60. The Pt-Spym does not induce
apoptosis in this tumour line.
In vivo toxicity test with male mouses BDF gave a DL50 value for the Pt-Spym compound of
250 mg/Kg. This value indicates that the toxicity is much lower than those of cisplatin or carboplatin,
which are the first and second generation platinum complexes used in clinical trials.
ACKNOWLEDGMENTS
We are grateful to DGICYT Ref. PB91-0806 and to Euroepan Community HCM, ref. ERBCHRXCT
920016 for financial support, to Johnson Matthey for K2PtCI4 suppfied, and C Alonso and VM
Gonzalez from Centro de Biolog/a Molecular, "’Severo Ochoa’; UAM, Cantoblanco, Madrid, for
biological tests.
REFERENCES
1. Gutierrez-Valero M.D., Romero-Molina M., L6pez-GarzSn R., Salas-Peregri’n J.M., Trans. Met.
Chem.,1988,13, 451.
2. Holy A., Votruba I., Jost K., FEBS Lett. ,1972, 22, 287.
3. Nowak M., Rostkowska H., Lapinski L., Leszczynski J., Kwiatkowskil J., Spec. Acta, 1991,
47A,339.
4. Lippert B., Arpalahti J., Krizanovic O., Micklitz W., Schwarz F., Trtscher G. in Nicolini M. (ed)
1987, Martinus Nijhoff Publishing, Boston
5. Goodgame D.M.L., Rollins R.W., Slawn A.M., Williams D.J., Zard PW; Inorg. Chim. Acta
,1986,120, 91
6. Abbot J., Goodgame D.M.L., Jeeves I.,J. Chem. Soc. Dalton ,1978, 880.
Rosenfield S.G., Berends H.P., Gelmini L., Stephan D.W., Mascharak P.K., Inorg. Chem. ,1987,
26, 2792.
8. Taqui Khan B., Bhatt J., Najmuddin K., Shamsuddin S., Annapoorna K., J. Inorg. Biochem.
,1991, 44, 55.
9. a) Goodgame D.M.L., Rollins R.W., Skapski A.C. Inorg. Chim. Acta ,1984, 83 L11 b) Goodgame
D.M.L., Slawn A.M., Williams D.J., Zard P.W., Inorg. Chim. Acta,1988, 148, 5
101
Battistuzzi R., Petronel G., Spectrochim. Acta 1980),36A, 113
112
Goel R., Gupta S., Sharma S., Gupta C., J.Chem.Soc.Faraday Trans.I1,1986, 82, 123
1 Contreras G., Seguel G., Alderete J., Spectrochim. Acta ,1994),50A, 371
13. Spinner E., J.Chem.Soc. ,1960,1237
14. Kennedy B.P., Lever A.B.P., Can. J.Chem. ,1972,50, 3488
15. Raper E.S., Coord.Chem.Rev. ,1985),61.1 15
16. Ginn V.C., Kelly P.F., Slawin A.M., Williams D.J., Woollins J.D., J.Chem.Soc.Dalton ,1992),963
17. Akovidis A., Hadjiliadis N., Coord.Chem.Rev. ,1994, 135, 17
18. De Sousa G.F., Filgueiras C.H., Trans.Met. Chem. ,1990),15, 290
19. Adams D.M.,1967, MetaI-Ligand and Related Vibrations, St Martin’s Press, New York.
17Vol. 4, No. 1, 1997 AntitumorActivity ofa Pt(III) Derivative of2-A/Iercaptopyrimidine
20. Mikulski C., De Prince R., Tran T., Inorg. Chim. Acta ,1981,56, 27
21. Nakamoto K., 1986, Infrared and Raman Spectra of Inorganic and Coordination Compounds,
4th ed, Wiley Interscience, Chichester
22. Berg R., Rasmussen K., Spectrochim. Acta ,1973),29A, 319
23. Stein P., Dickson M., Roundhill D.,J.Am.Chem.Soc. ,1983, 105, 3489
24. Che C., Schaefer W., Gray H., Dickson M., Stein P., Roundhill D., J.Am.Chem.Soc. ,1982, 104,
4253
25. Lippert B., Schollholm H., Thewald U., Inorg. Chem. ,1986, 25, 407.
26. Alexander K., Bryan S., Fronczek F., Fultz W., Rheingold A., Roundhill D., Stein P., Watkins S.,
Inorg. Chem. ,1985, 24, 2803
27. Woollins J.D., Kelly P.F. Coord.Chem.Rev. ,1985, 65, 115
28. Chenon M., Pugmire R., Grant D.M., Panzica R., Townsend L., J.Am.Chem.Soc. ,1975),97,
4627
29. Seddon K., Turp J., Constable E., Wernberg O., J.Chem.Soc.Dalton ,1987, 293
30. Pregosin P. (ed), 1991, Transition Metal Nuclear Magnetic Resonance, Elsevier, Z0rich.
31. WienkStter T., Sabat M., Fusch G., Lippert B., Inorg. Chem. ,1995),34, 1022
32. Johnson A., Qu Y., Van Houten B., Farrell N., Nucl. Acid Res. ,1992, 20, 1697
33. McConnaughie A., Jenkins T., J.Med.Chem. ,1995),38, 3488
34. Keck M., Lippard S.J.,J.Am.Chem.Soc. ,1992, 114, 3386
35. Farrell N. (ed) ,1989, Transition Metal Complexes as Drugs and Chemotherapeutic Agents,
Kluwer Academic Publishers, Dordrecht
36. Lowe S.W., Ruley H.E., Jacks T., Housman D.E.,Cell ,1993,74, 957
Received" January 3, 1997- Accepted" January 21, 1997-
Received in revised camera-ready format: January 23, 1997
18